Caredx Inc Stock

Description CareDx

CareDx is a publicly-traded biotechnology company that specializes in developing and commercializing diagnostic solutions for solid organ and cell-based transplantation. The company's main focus is on transplant patients and developing solutions that offer improved outcomes and streamlined processes for medical professionals.

CareDx provides a range of products and services, including diagnostic assays, monitoring services, and cloud-based software solutions. These products and services are designed to help healthcare providers more accurately monitor transplant patients, predict potential clinical issues, and manage post-transplant care more effectively.

The company was founded in 1998 and is headquartered in Brisbane, California. CareDx's stock is listed on the Nasdaq Global Market under the ticker symbol "CDNA". The company has a market capitalization of around $2.6 billion as of June 2021, and its stock has shown strong growth in recent years, driven by rising demand for its products and services.